Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly.
Physicians need to perform their due diligence and practice caution when prescribing addictive pain medications to relieve their patients' chronic pain due to increased federal monitoring of pain prescriptions.